Michael Scolaro

Michael Scolaro

Oct 16, 2017

Group 6 Copy 156
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Decreasing the Risk of Death and Diving Injuries in Artisanal Fishermen

Artisanal fishermen risk their lives every day to support their families and communities. Using outdated...

What's Calcium's role in heart and kidney disease?

Hardening of the arteries, or atherosclerosis, is a global problem leading to heart attacks and strokes...

Can we predict whether an athlete will sustain an ACL tear?

Despite consistent investigation, the risk factors responsible for non-contact Anterior Cruciate Ligament...

Backer Badge Funded